Baymatob
Leichhardt
About Baymatob
Baymatob is an AI-guided solution to improve health outcomes for mothers and their babies. The company was founded after the traumatic birth experience Dr Sarah McDonald, a mechatronic engineer with a PhD in medicine. Oli PPH is Baymatob's first AI-guided medical product based on the Oli maternity sensor, monitoring and diagnostic platform. Oli PPH is the only product to have ever demonstrated the ability to identify women who are at higher risk of developing postpartum hemorrhage well before they give birth, allowing for early prediction and clinical actions to prevent the leading cause of preventable maternal death. Oli PPH was recently granted Breakthrough Device Designation by the U.S. Food and Drug Administration.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2022)
- Website: baymatob.com
- Phone: +61 2 8971 7412
Industries & Categories
Artificial Intelligence (AI), Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/baymatob-2126 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.